Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos
Johnson & Johnson Seeks FDA Approval for Covid Booster Shot in Adults
Posted
October 5, 2021
Views
2,443
Likes
30
Comments
2
Engagement
October 5, 2021
2,443
30
2
1.31%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:53Now PlayingJohnson & Johnson asked the U.S. Food and Drug Administration to authorize a second dose of its Covid-19 vaccine for adults after a study showed it provided strong protection against infection.
The submission includes results from a late-stage clinical trial that found a booster dose of its one-shot vaccine given 56 days after the first inoculation provided 94% protection against moderate to severe disease in the U.S., the company said in a statement on Tuesday.
Subscribe to our YouTube channel
Subscribe to our newest channel Quicktake Explained
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
